Literature DB >> 9685921

On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix.

M C Bonferoni1, S Rossi, F Ferrari, M Bertoni, G K Bolhuis, C Caramella.   

Abstract

The lambda carrageenan/HPMC ratio in matrix tablets has been optimized in order to obtain pH-independent release profiles of chlorpheniramine maleate, a freely soluble drug. Release profiles in acidic (pH1.2) and neutral (pH 6.8) media were fitted according to the Weibull and the power law models. Model independent parameters(t50% and the percentage of drug released after 2 h) were also calculated. The Weibull parameters were found suitable to describe the dependence of the release profiles on matrix composition. Preparation and testing of the optimized formulation showed linear and pH-independent release profiles lasting about 24 h, in good accordance with the values predicted by the optimization procedure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685921     DOI: 10.1016/s0168-3659(97)00175-2

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

1.  A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function.

Authors:  Kosmas Kosmidis; Panos Argyrakis; Panos Macheras
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

2.  Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices.

Authors:  Kiran S Bhise; Ravindra S Dhumal; Bhaskar Chauhan; Anant Paradkar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2007-06-15       Impact factor: 3.246

3.  A design and evaluation of layered matrix tablet formulations of metoprolol tartrate.

Authors:  Esra Baloğlu; Taner Senyiğit
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

4.  Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.

Authors:  Elena Soto; Sebastian Haertter; Michael Koenen-Bergmann; Alexander Staab; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2009-12-29       Impact factor: 4.200

5.  Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.

Authors:  Carola Aguzzi; Maria Cristina Bonferoni; Maria Rosario Osorio Fortich; Silvia Rossi; Franca Ferrari; Carla Caramella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

6.  Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.

Authors:  M C Bonferoni; S Rossi; F Ferrari; E Stavik; A Pena-Romero; C Caramella
Journal:  AAPS PharmSciTech       Date:  2000-06-17       Impact factor: 3.246

7.  Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.

Authors:  Ruggero Bettini; Maria Cristina Bonferoni; Paolo Colombo; Laura Zanelotti; Carla Caramella
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

Review 8.  Marine Origin Polysaccharides in Drug Delivery Systems.

Authors:  Matias J Cardoso; Rui R Costa; João F Mano
Journal:  Mar Drugs       Date:  2016-02-05       Impact factor: 5.118

9.  Chitosan Ascorbate Nanoparticles for the Vaginal Delivery of Antibiotic Drugs in Atrophic Vaginitis.

Authors:  Silvia Rossi; Barbara Vigani; Antonella Puccio; Maria Cristina Bonferoni; Giuseppina Sandri; Franca Ferrari
Journal:  Mar Drugs       Date:  2017-10-19       Impact factor: 5.118

10.  Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions.

Authors:  Maximilian Sager; Philipp Schick; Magdalena Mischek; Christian Schulze; Mahmoud Hasan; Marie-Luise Kromrey; Hassan Benameur; Martin Wendler; Mladen Vassilev Tzvetkov; Werner Weitschies; Mirko Koziolek
Journal:  Pharmaceutics       Date:  2019-12-07       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.